4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019266
EVP, Chief R&D Officer gave up 1,629 shares (to pay taxes)
- EVP, Chief R&D Officer acquired 19,150 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Friberg Gregory R · EVP, Chief R&D Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Grant or award : show line 1 in the form | +19,150 | 56,728 | D | ||
| 2026-03-17 | Shares withheld for taxes : show line 2 in the form | −1,629 | $56.05 | $91,305 | 55,099 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-16 | Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) | +45,600 | 45,600 | D |
Loading xslF345X06/wk-form4_1773855579.xml…